Patient-Focused Medical Strategies for Driving Outcomes

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Patient-Focused Impact: Medical Strategies and Tactics That Drive Outcomes”

STUDY OVERVIEW

In an era where real-world signals shape clinical and commercial decisions, Medical Affairs has become the organization’s compass—guiding strategy with patient experience, evidence, and frontline scientific insight. Today’s leaders are expected not only to understand evolving care patterns but to translate those insights into focused strategies that influence diagnosis quality, treatment decision-making, and overall patient well-being.

This study from Best Practices, LLC examines how top companies design Medical strategies that put patient outcomes at the forefront. It explores how organizations embed patient voice into planning, integrate RWE and PROs to identify care gaps, refine scientific exchange focus areas, and equip field teams to drive deeper, outcomes-aligned engagement. It also highlights the technologies advancing early insight generation and the mindsets enabling stronger Medical planning discipline.

Drawing on benchmarks across large, mid-small, connected, and siloed organizations, the study provides Medical Affairs leaders with clear direction to sharpen strategy development, elevate evidence-informed prioritization, and build Medical plans that reliably translate to improved real-world outcomes.

KEY TOPICS

Outcomes-driven Medical strategy frameworks
High-impact tactics for improving patient care
Integration of RWE and PROs into workflows
Role of AI and digital tools in Medical Affairs

KEY METRICS

Role of improved outcomes in Medical strategy
Outcomes-driven medical strategy
Driving impact with an outcomes-driven approach
High-impact tactics for improving patient outcomes
Effective field medical topics for driving better patient outcomes
Innovative technologies adopted by Medical Affairs to enhance patient outcomes

SAMPLE KEY FINDINGS

High-impact tactics: Connected organizations drive better outcomes by 1) wielding RWE across customer touchpoints (including Field), 2) using personalized omnichannel engagement approaches to shift care behaviors, 3) incorporating patient-friendly trial design (and MSL-driven enrollment), and 4) addressing health disparities within sub-populations.

METHODOLOGY

Best Practices LLC conducted a benchmark survey with 27 Medical Affairs leaders from 21 biopharma companies, supplemented by deep-dive interviews to capture real-world examples and strategic insights.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Clinical Research; Laboratories

Companies Profiled:
AbbVie; ADVANZ PHARMA; Alnylam Pharmaceuticals; argenx; Arrowhead Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Biogen; Boehringer Ingelheim; Cytokinetics; Eva Pharma; Ferring Pharmaceuticals; Gr�nenthal; Insmed; Jazz Pharmaceuticals; Merck; Otsuka; Sanofi; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Patient-Focused Impact: Medical Strategies and Tactics That Drive Outcomes

ID: 5901

Features:

Pages/Slides: 43

Published: 2025

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62766D97B10ACF65A00258D4D002EB681
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-patient-focused-impact-medical-strategies-tactics-drive-outcomes?opendocument
18
19opendocument
2018.97.14.90
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB